SFORZA, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 1.365
EU - Europa 466
AS - Asia 191
AF - Africa 2
Totale 2.024
Nazione #
US - Stati Uniti d'America 1.364
PL - Polonia 148
CN - Cina 122
IT - Italia 111
UA - Ucraina 73
GB - Regno Unito 49
DE - Germania 40
TR - Turchia 38
SG - Singapore 23
FI - Finlandia 18
SE - Svezia 13
BE - Belgio 11
IR - Iran 3
TN - Tunisia 2
VN - Vietnam 2
CA - Canada 1
CZ - Repubblica Ceca 1
FR - Francia 1
ID - Indonesia 1
IN - India 1
JP - Giappone 1
RO - Romania 1
Totale 2.024
Città #
Fairfield 199
Ann Arbor 180
Warsaw 148
Woodbridge 142
Houston 122
Chandler 96
Jacksonville 95
Ashburn 94
Cambridge 76
Ferrara 70
Seattle 61
Wilmington 61
Beijing 43
Izmir 25
Nanjing 19
Princeton 19
San Diego 18
Milan 17
Shanghai 15
Boardman 13
Brussels 11
Singapore 9
Mountain View 8
Nanchang 8
Shenyang 8
Addison 6
Changsha 6
Hebei 6
Redwood City 6
Jiaxing 5
Bremen 4
Cagliari 4
London 4
Los Angeles 4
New York 4
Ardabil 3
Kunming 3
Modena 3
Tianjin 3
Dearborn 2
Dong Ket 2
Falls Church 2
Guangzhou 2
Indiana 2
Jinan 2
Leawood 2
Rome 2
San Mateo 2
Auburn Hills 1
Augusta 1
Bologna 1
Brno 1
Camerino 1
Chiswick 1
Farmville 1
Forest City 1
Fuzhou 1
Helsinki 1
Jakarta 1
La Canada Flintridge 1
Lanzhou 1
Montréal 1
Munich 1
New Bedfont 1
Norwalk 1
Orange 1
Osimo 1
Prescot 1
Redmond 1
San Francisco 1
Taranto 1
Tokyo 1
Yellow Springs 1
Totale 1.661
Nome #
The HIV-Tat protein favors the activation of T lymphocytes. Implications for new therapeutic strategies against HIV and other viral infections 176
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 148
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 127
Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides 125
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: production, characterization and in vitro studies 123
Synthesis, characterization and antiproliferative activity of three platinum(II) complexes of L-​carnitine. The first structural determination of a platinum complex containing carnitine 119
Acetylcholine-like and Trimethylglycine-like PTA (1,3,5-Triaza-7-phosphaadamantane) Derivatives for the Development of Innovative Ru- and Pt-Based Therapeutic Agents 109
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 109
null 107
null 106
UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion 106
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 105
Platinum and ruthenium complexes of new long-tail derivatives of PTA (1,3,5-triaza-7-phosphaadamantane): Synthesis, characterization and antiproliferative activity on human tumoral cell lines 101
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors. 100
Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs 99
Unexpected One-Pot Synthesis of Highly Conjugated Pentacyclic Diquinoid Compounds 86
New PTA (1,3,5-triaza 7-phosphaadamantane) derivatives associating zwitterionic structure and coordinativa ability 83
Modified N,O-nucleosides: design, synthesis and evaluation of the antitumor activity 55
null 43
Synthesis and in vitro cytotoxicity of deoxyadenosine-​bile acid conjugates linked with 1,​2,​3-​triazole 21
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 16
Totale 2.064
Categoria #
all - tutte 7.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020516 78 22 21 71 35 55 46 48 43 47 36 14
2020/2021337 33 26 12 34 13 32 16 42 20 58 40 11
2021/2022226 9 20 23 11 5 9 21 11 13 17 25 62
2022/2023217 23 6 13 35 29 26 17 23 27 1 11 6
2023/2024107 9 19 4 0 6 22 4 12 2 3 0 26
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 2.064